Lattice Semiconductor Corporation (NASDAQ:LSCC) today announced that it is scheduled to present at Jefferies Semiconductors, Hardware & Communications Infrastructure Summit taking place on Wednesday, August 27th at the Ritz Carlton in Chicago. Lattice Semiconductor Corporation (NASDAQ:LSCC) belongs to Technology sector. Its net profit margin is 10.50% and weekly performance is 4.81%. On last trading day company shares ended up $7.53. Lattice Semiconductor Corporation (NASDAQ:LSCC) distance from 50-day simple moving average (SMA50) is -1.94%.
CVS Caremark Corporation (NYSE:CVS) announced today the early tender results, applicable Reference Yields and consideration payable in connection with its previously announced cash tender offers (the “Tender Offers”) commenced on August 7, 2014 for (1) any and all of its 6.250% Senior Notes due 2027 (the “Any and All Notes”) and (2) up to a maximum amount of its 6.125% Senior Notes due 2039, 5.750% Senior Notes due 2041 and 5.750% Senior Notes due 2017 (collectively, the “Maximum Tender Offer Notes” and together with the Any and All Notes, the “Notes”). CVS Caremark Corporation (NYSE:CVS) shares moved up 0.33% in last trading session and ended the day at $79.24. CVS Gross Margin is 18.70% and its return on assets is 6.90%. CVS Caremark Corporation (NYSE:CVS) quarterly performance is 3.12%.
Silicom Ltd (Nasdaq:SILC) announced that one of its customers has decided to replace the networking cards it currently uses in approximately 10 appliances with a variety of advanced Silicom networking cards. In addition, the customer is considering replacing its current SSL acceleration solution with Silicom’s new Coleto Creek-based card.On 23 August, Silicom Ltd. (NASDAQ:SILC) shares decreased -0.21% and was closed at $29.08. SILC EPS growth in last 5 year was 52.04%. Silicom Ltd. (NASDAQ:SILC) year to date (YTD) performance is -35.36%.
Roth Capital reissued their buy rating on shares of Galena Biopharma (NASDAQ:GALE) in a research report released on Thursday morning.Galena Biopharma, Inc. (NASDAQ:GALE) ended the last trading day at $2.15. Company weekly volatility is calculated as 5.96%and price to cash ratio as 6.48. Galena Biopharma, Inc. (NASDAQ:GALE) showed a weekly performance of -15.02%.
Alexander & Baldwin (NASDAQ:ALEX)‘s stock had its “buy” rating reiterated by equities research analysts at Compass Point in a research note issued to investors on Friday.Alexander & Baldwin, Inc. (NYSE:ALEX) shares moved up 0.94% in last trading session and ended the day on $40.89. ALEX Gross Margin is 22.10% and its return on assets is 3.20%. Alexander & Baldwin, Inc. (NYSE:ALEX) quarterly performance is 6.32%.